Cronos Group Inc. - Common Share (CRON)
2.0700
+0.0100 (0.49%)
Cronos Group is a leading global cannabinoid company focused on the research, development, and production of smoked and non-smoked cannabis products
The company operates multiple brands and offers a wide range of cannabis-based products, including oils, capsules, and edibles, catering to both medicinal and recreational markets. Cronos Group is committed to innovative research and development efforts aimed at advancing the cannabis industry, and it emphasizes sustainability and compliance with regulatory standards across its operations. By leveraging strategic partnerships and investments in technology, the company seeks to enhance its market presence and drive growth in the evolving landscape of cannabis consumption.
Previous Close | 2.060 |
---|---|
Open | 2.050 |
Bid | 2.060 |
Ask | 2.070 |
Day's Range | 2.035 - 2.110 |
52 Week Range | 1.860 - 3.140 |
Volume | 1,347,437 |
Market Cap | 769.64M |
PE Ratio (TTM) | -18.82 |
EPS (TTM) | -0.1 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,288,862 |
News & Press Releases
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainersbenzinga.com
Via Benzinga · January 1, 2025
Foreign Companies Could Tap into Germany’s Marijuana Pilot Programs
Non-German companies could potentially benefit from new recreational marijuana pilot programs in Germany, observers say. The European nation partially decriminalized adult-use cannabis on April 1, 2024, becoming the 9th country in the world to legalize cannabis and granting millions of Germans access to the drug.
Via CannabisNewsWire · December 27, 2024
420 with CNW — Elton John Thinks Marijuana Legalization in Canada, the US is a Grave Mistake
Elton John has been vocal about his stance on the legalization of cannabis, openly criticizing its approval in parts of the United States and Canada. The legendary musician expressed strong concerns about the drug, reflecting on his own experiences and observations during a Time magazine interview .
Via CannabisNewsWire · December 19, 2024
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demandbenzinga.com
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Via Benzinga · December 5, 2024
What Marijuana Reclassification Could Mean for Washington D.C.
In 2022, the Biden Administration initiated efforts to reevaluate how cannabis is classified under federal law, leading the DEA to start a formal rule-making procedure this year.
Via CannabisNewsWire · December 5, 2024
420 with CNW — Nebraska AG Pledges That Ongoing Investigations Won’t Impact Cannabis Measure’s Certification
Mike Hilgers, Nebraska’s Attorney General, assured the public on Tuesday that his office’s current investigations into two medical marijuana ballot measures will not affect his decision to certify the election results . Speaking at a press conference on an unrelated lawsuit, Hilgers stated that the election certification process would proceed independently of the marijuana-related legal disputes or the timing of any court ruling.
Via CannabisNewsWire · December 2, 2024
420 with CNW — Study Finds That Not Everyone Can Improve Their Sleep by Using Marijuana
A recent study suggests that marijuana’s impact on sleep may differ depending on an individual’s mental health background.
Via CannabisNewsWire · November 18, 2024
Cronos CEO Mike Gorenstein Says He's Optimistic About Trump's Impact On Cannabisbenzinga.com
Cronos CEO Mike Gorenstein discusses Trump's potential for cannabis reform, challenges the "blue state" myth, and Cronos' focus...
Via Benzinga · November 14, 2024
Cronos Group Q3 Financials; Total Net Revenue Was Up; International Sales Were Up 29%talkmarkets.com
In the third quarter, Cronos' Spinach brand became the best-selling cannabis brand in the Canadian adult-use market and their Peace Naturals brand held a top spot in the Israeli medical market.
Via Talk Markets · November 13, 2024
Why Cronos Group Stock Popped 9% Todayfool.com
Cronos stock just went up -- a lot. Maybe it's time to sell?
Via The Motley Fool · November 12, 2024
Cronos Group (CRON) Q3 2024 Earnings Call Transcriptfool.com
CRON earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 12, 2024
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabisbenzinga.com
Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.
Via Benzinga · November 12, 2024
Cronos Cannabis Co. Reports 38% YOY Increase In Q3 Revenue, Boosts International Salesbenzinga.com
Cronos' Q3 net revenue totaled $34.3 million, up by $9.5 million year-over-year. Q3 net income totaled $7.3 million compared to a net loss of $1.6 million in the prior year's period. The company has set an operating expense savings target of $5 to $10 million for 2024,
Via Benzinga · November 12, 2024
Cronos Group Reports 2024 Third Quarter Results
Net revenue in Q3 2024 increased by 38% year-over-year to $34.3 million
By Cronos Group Inc. · Via GlobeNewswire · November 12, 2024
420 with CNW — Fighters in Nevada Are No Longer Prohibited from Using Marijuana
The Nevada State Athletic Commission (NSAC) recently removed marijuana from its list of prohibited substances. This change means that fighters in the state who possess, use, or consume marijuana products will no longer face penalties for violating anti-doping rules.
Via CannabisNewsWire · November 6, 2024
Cannabis Stocks Sink Amid Broader Market Decline And Election Jittersbenzinga.com
Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.
Via Benzinga · October 31, 2024
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Groundbenzinga.com
Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies.
Via Benzinga · October 29, 2024
Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024
TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.
By Cronos Group Inc. · Via GlobeNewswire · October 29, 2024
420 with CNW — Arkansas Supreme Court Says Cannabis Amendment Ballots in November Will Not Count
The Arkansas Supreme Court decided in a narrow 4-3 ruling that votes in favor of and against a plan to broaden the state’s medical cannabis program would not be taken into account. Protect Arkansas Kids, a nonprofit that joined the legal fight against the amendment—Issue 3, filed a case that resulted in this decision. The votes cast on Issue 3 will be ignored, even though it will still be on the ballot in November.
Via CannabisNewsWire · October 28, 2024